As of my last update in October 2023, specific information about the chemical substance BDM91288 (CAS number 2892824-53-0) is limited in publicly available databases. Generally, substances with unique identifiers like CAS numbers are often researched for their potential applications in various fields, including pharmaceuticals, materials science, or biochemistry. Characteristics of such compounds typically include their molecular structure, solubility, stability, reactivity, and biological activity, which can be influenced by functional groups and overall molecular geometry. For precise details, including safety data, synthesis methods, and specific applications, consulting specialized chemical databases, scientific literature, or safety data sheets (SDS) is recommended. Additionally, researchers may need to refer to proprietary information or studies published in scientific journals for comprehensive insights into the properties and uses of BDM91288.

BDM91288

2892824-53-0: As of my last update in October 2023, specific information about the chemical substance BDM91288 (CAS number 2892824-53-0) is limited in publicly available databases. Generally, substances with unique identifiers like CAS numbers are often researched for their potential applications in various fields, including pharmaceuticals, materials science, or biochemistry. Characteristics of such compounds typically include their molecular structure, solubility, stability, reactivity, and biological activity, which can be influenced by functional groups and overall molecular geometry. For precise details, including safety data, synthesis methods, and specific applications, consulting specialized chemical databases, scientific literature, or safety data sheets (SDS) is recommended. Additionally, researchers may need to refer to proprietary information or studies published in scientific journals for comprehensive insights into the properties and uses of BDM91288.

<p>BDM91288, an orally active AcrB efflux pump inhibitor of pyridinium piperazine, enhances the in vivo efficacy of levofloxacin in treating Klebsiella pneumoniae pulmonary infection in mouse models [1].</p>

CAS 2892824-53-0

BDM91288

BDM91288

Ref: TM-T85817